These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 12398576)
1. Meningococcal vaccine use in college students. Kelleher JA; Raebel MA Ann Pharmacother; 2002 Nov; 36(11):1776-84. PubMed ID: 12398576 [TBL] [Abstract][Full Text] [Related]
2. An Update on Meningococcal Vaccination. Garland JM R I Med J (2013); 2020 Aug; 103(6):41-43. PubMed ID: 32752565 [TBL] [Abstract][Full Text] [Related]
3. Impact of serogroup A meningococcal conjugate vaccine for Africa. Stuart JM Hum Vaccin Immunother; 2018 May; 14(5):1116-1117. PubMed ID: 29194010 [TBL] [Abstract][Full Text] [Related]
4. Serogroup B Meningococcal Disease Vaccine Recommendations at a University, New Jersey, USA, 2016. Soeters HM; Dinitz-Sklar J; Kulkarni PA; MacNeil JR; McNamara LA; Zaremski E; Chang HY; Lujan E; Granoff D; Lasky M; Montana B Emerg Infect Dis; 2017 May; 23(5):867-869. PubMed ID: 28418307 [TBL] [Abstract][Full Text] [Related]
5. Neisseria meningitidis B vaccines. Panatto D; Amicizia D; Lai PL; Gasparini R Expert Rev Vaccines; 2011 Sep; 10(9):1337-51. PubMed ID: 21919622 [TBL] [Abstract][Full Text] [Related]
6. Cost calculator for mass vaccination response to a US college campus outbreak of serogroup B meningococcal disease. La EM; Talbird SE; Kanadanian KV; Huang L; Fain J; Srivastava A Hum Vaccin Immunother; 2019; 15(4):978-986. PubMed ID: 30526279 [TBL] [Abstract][Full Text] [Related]
7. [Meningococcus B: control of two outbreaks by vaccination]. Gabutti G J Prev Med Hyg; 2014 Jun; 55(2):35-41. PubMed ID: 25916017 [TBL] [Abstract][Full Text] [Related]
8. Prospects and challenges with introduction of a mono-valent meningococcal conjugate vaccine in Africa. Okoko BJ; Idoko OT; Adegbola RA Vaccine; 2009 Mar; 27(14):2023-9. PubMed ID: 19095025 [TBL] [Abstract][Full Text] [Related]
9. US College Students Are at Increased Risk for Serogroup B Meningococcal Disease. Marshall GS; Dempsey AF; Srivastava A; Isturiz RE J Pediatric Infect Dis Soc; 2020 Apr; 9(2):244-247. PubMed ID: 31077326 [TBL] [Abstract][Full Text] [Related]
10. Eliminating epidemic Group A meningococcal meningitis in Africa through a new vaccine. LaForce FM; Okwo-Bele JM Health Aff (Millwood); 2011 Jun; 30(6):1049-57. PubMed ID: 21653956 [TBL] [Abstract][Full Text] [Related]
11. Infectious disease. Shortage of meningitis vaccine forces triage in Burkina Faso. Vogel G Science; 2003 Mar; 299(5612):1499-501. PubMed ID: 12624241 [No Abstract] [Full Text] [Related]
12. [Health Technology Assessment of meningococcal B vaccine (Trumenba Boccalini S; Bechini A; Sartor G; Paolini D; Innocenti M; Bonanni P; Panatto D; Lai PL; Zangrillo F; Marchini F; Lecini E; Iovine M; Amicizia D; Landa P J Prev Med Hyg; 2019 Dec; 60(3 Suppl 2):E1-E94. PubMed ID: 32047867 [No Abstract] [Full Text] [Related]
14. Clinical experience with the meningococcal B vaccine, Bexsero(®): Prospects for reducing the burden of meningococcal serogroup B disease. Watson PS; Turner DP Vaccine; 2016 Feb; 34(7):875-80. PubMed ID: 26686570 [TBL] [Abstract][Full Text] [Related]
15. An outbreak of serogroup C meningococcal disease in the province of Antwerp (Belgium) in 2001-2002. De Schrijver K; Maes I Eur J Epidemiol; 2003; 18(11):1073-7. PubMed ID: 14620942 [TBL] [Abstract][Full Text] [Related]
16. Use of a multicomponent, recombinant, meningococcal serogroup B vaccine (4CMenB) for bacterial meningitis prevention. Esposito S; Castellazzi L; Bosco A; Musio A; Stoddard J Immunotherapy; 2014; 6(4):395-408. PubMed ID: 24815780 [TBL] [Abstract][Full Text] [Related]
17. Infectious disease. An ill wind, bringing meningitis. Roberts L Science; 2008 Jun; 320(5884):1710-5. PubMed ID: 18583588 [No Abstract] [Full Text] [Related]
18. Meningococcal meningitis prevention programs for college students: a review of the literature. Butler KM Worldviews Evid Based Nurs; 2006; 3(4):185-93. PubMed ID: 17177931 [TBL] [Abstract][Full Text] [Related]
19. Positive effect of meningococcal C vaccination on serogroup replacement in Neisseria meningitidis. Pérez-Trallero E; Vicente D; Montes M; Cisterna R Lancet; 2002 Sep; 360(9337):953. PubMed ID: 12354504 [No Abstract] [Full Text] [Related]
20. Developmental strategy for a new Group A meningococcal conjugate vaccine (MenAfriVac Kulkarni PS; Jadhav SS; LaForce FM Hum Vaccin Immunother; 2018 May; 14(5):1103-1106. PubMed ID: 29048988 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]